Drs. Rohit Gosain and Rahul Gosain, the Oncology Brothers, are board certified in internal medicine, hematology, and oncology. They work in the community setting as generalists, and their mission is to bridge the gap between the community and academia by providing key insights and succinct conference updates, discussing practice-changing data, and reiterating the standard of care.
Featured Videos
An Effective and Easy-to-Use Algorithm for Treating Small Cell Lung Cancer
In this podcast episode, The Oncology Brothers are joined by Dr. Estelamari Rodriguez, University of Miami Health System, to discuss her approach for treating small cell lung cancer (SCLC). Dr. Rodriguez, who serves as the Associate Director of Community Outreach - Thoracic Oncology at...
A Top-Notch Treatment Algorithm for Localized Non-Small Cell Lung Cancer
The Oncology Brothers are joined by nationally renowned researcher and thoracic oncologist Charu Aggarwal, MD, MPH, of Penn Center for Precision Medicine, to discuss a treatment algorithm for localized non-small cell lung cancer (NSCLC). The trio detail the best treatment approaches for stage I-III...
Neoadjuvant-Adjuvant Pembrolizumab Therapy Increases Survival in Advanced Skin Cancer
The Oncology Brothers are joined by Dr. Sapna Patel, Director of Unveal Melanoma, Program Director of Melanoma Fellowship, and Associate Professor at the University of Texas - MD Anderson Cancer Center, to discuss melanoma highlights from ESMO 2022. Among the studies discussed, the group...
MOUNTAINEER Study: An Effective Treatment Combination For Metastatic Colorectal Cancer
In this podcast episode, the Oncology Brothers (Drs. Rohit & Rahul Gosain) are joined by Dr. Tanios Bekaii-Saab, Mayo Clinic Comprehensive Cancer Center, to discuss the MOUNTAINEER Phase II study, which prompted the FDA approval of tucatinib in combination with trastuzumab in treating advanced...
Assessing a Treatment Algorithm for Triple Negative Breast Cancer
Dr. Shirpa Gandhi, Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center, joins the Oncology Brothers (Drs. Rohit & Rahul Gosain) to detail a treatment algorithm for triple negative breast cancer (TNBC) based on disease stage. The trio also analyzed two cases of...
Analyzing an Algorithm For HER2 Neu Positive Breast Cancer
In this podcast episode, the Oncology Brothers (Drs. Rohit & Rahul Gosain) are joined by Dr. Erika Hamilton, Director of Breast & Gynecologic Cancer Research, Sarah Cannon Research Institute. Dr. Hamilton detailed her approach to treating HER 2/Neu positive breast cancer using an algorithm...
Reviewing An Algorithm For Hormone Receptor Positive Breast Cancer
The Oncology Brothers (Drs. Rohit & Rahul Gosain) speak with Dr. Stephanie Graff, Director of Breast Oncology, Associate Professor of Medicine at Lifespan Cancer Institute, Brown University, about an innovative algorithm for determining the optimal treatment regimen for patients with Hormone Receptor Positive Breast...
Trastuzumab Deruxtecan Increases Survival in HER2-low Metastatic Breast Cancer
In this interview, Dr. Shanu Modi - Professor of Medicine at Memorial Sloan Kettering Cancer Center, talked with the Oncology Brothers (Drs. Rohit and Rahul Gosain) about the DESTINY-Breast04 study, of which Dr. Modi was the lead investigator. This important analysis found that the...
Neoadjuvant Immunotherapy Demonstrates Promising Results in Colon Cancer
Dr. Myriam Chalabi, an oncologist at Netherlands Cancer Institute, spoke with the Oncology Brothers (Drs. Rohit and Rahul Gosain) to discuss the NICHE-2 study, which assessed the use of neoadjuvant immunotherapy in deficient mismatch repair (dMMR) colon cancer. In this study consisting of 112...
FDA-Approved Elacestrant Is Clinically Effective at Treating Advanced or Metastatic Breast Cancer
Aditya Bardia, MD, MPH, associate professor at Massachusetts General Hospital, Harvard Medical School, spoke with The Oncology Brothers about the EMERALD study. This randomized, open-label, active-controlled, multicenter trial found that elacestrant yields better progression-free survival compared with standard of care in ER+, HER2-metastatic breast...
Practice-Changing Studies Presented at ASCO GI 2023
Rohit Gosain, MD, and Rahul Gosain, MD, known as the Oncology Brothers, talk highlights from ASCO GI 2023 with Mark Lewis, MD, a cancer survivor and director of gastrointestinal oncology at Intermountain Healthcare. Some of the studies covered include: The SPOTLIGHT analysis of zolbetuximab...
Use This Algorithm to Treat Upper GI Malignancies
Rutika Mehta, MD, assistant professor of oncology at the Moffitt Cancer Center, discusses treatment options for upper gastrointestinal cancer (including esophageal, esophagogastric junction , and gastric cancers) that can be used in practice to inform standard of care in the community oncology setting.
Meet the Oncology Brothers
Dr. Rahul Gosain’s Disclosures
Advisory Board: AstraZeneca
Advertisement